As of 2026-03-23, the Intrinsic Value of Medtronic PLC (MDT) is 107.77 USD. This Medtronic valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 86.16 USD, the upside of Medtronic PLC is 25.10%.
The range of the Intrinsic Value is 71.03 - 202.05 USD
Based on its market price of 86.16 USD and our intrinsic valuation, Medtronic PLC (MDT) is undervalued by 25.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 71.03 - 202.05 | 107.77 | 25.1% |
| DCF (Growth 10y) | 94.86 - 245.69 | 137.45 | 59.5% |
| DCF (EBITDA 5y) | 87.38 - 113.04 | 99.03 | 14.9% |
| DCF (EBITDA 10y) | 108.61 - 147.35 | 126.00 | 46.2% |
| Fair Value | 17.98 - 17.98 | 17.98 | -79.14% |
| P/E | 105.42 - 130.65 | 118.61 | 37.7% |
| EV/EBITDA | 77.66 - 131.43 | 108.17 | 25.5% |
| EPV | 49.34 - 71.60 | 60.47 | -29.8% |
| DDM - Stable | 31.68 - 94.62 | 63.15 | -26.7% |
| DDM - Multi | 67.10 - 145.54 | 90.77 | 5.4% |
| Market Cap (mil) | 110,619.10 |
| Beta | 0.64 |
| Outstanding shares (mil) | 1,283.88 |
| Enterprise Value (mil) | 137,543.10 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.68% |
| Cost of Debt | 4.39% |
| WACC | 7.65% |